COVID-19 update: Genoskin to maintain US production activity during pandemic.
Genoskin COVID-19 research preferred access program On Friday, March 13th 2020,
Genoskin develops and markets innovative testing tools to study the effects of pharmaceutical, cosmetic and chemical products on real, live ex vivo human skin.
Genoskin awarded the Healthtech prize “Transformons la France!”
16 October 2020
Genoskin answers questions from National Anti-Vivisection Society
7 October 2020
Genoskin & LEO Pharma publish data on inflammation model InflammaSkin® in Experimental Dermatology
2 October 2020
Pharma’s Almanac: Overcoming skin assays challenges with living human skin models
30 September 2020
We are hiring! Join our team as our first CFO!
10 September 2020